<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="359">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701944</url>
  </required_header>
  <id_info>
    <org_study_id>7794</org_study_id>
    <nct_id>NCT04701944</nct_id>
  </id_info>
  <brief_title>Clinical Study of Pregnant Women With COVID-19</brief_title>
  <acronym>PregWom-Covid</acronym>
  <official_title>Clinical Study of Pregnant Women With COVID-19: A Retrospective Review of Medical Records at Strasbourg University Hospitals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new pandemic, COVID-19, has spread rapidly around the world. She does not spare pregnant&#xD;
      women. Little is known about the clinical course of pregnant women infected with COVID-19. As&#xD;
      of April 1, 2020, six case series and one case report for a total of 61 pregnancies affected&#xD;
      by COVID-19, all from the pandemic epicenter in China, except for one state case report&#xD;
      -Unis, have been published. These preliminary reports suggest that pregnant women are not&#xD;
      more seriously affected than the general population and show a certain gap with what we have&#xD;
      observed in the care of pregnant women at HUS. For these reasons, additional information,&#xD;
      especially from parts of the world other than China, as the severity of the disease can vary&#xD;
      from country to country, is urgently needed to determine whether pregnant women with the&#xD;
      disease of COVID-19 will not present with severe pneumonia to COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2020</start_date>
  <completion_date type="Anticipated">April 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 21, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A retrospective review of the medical records of pregnant women with COVID-19 at the University Hospitals of Strasbourg</measure>
    <time_frame>Files analysed retrospectively from March 01, 2020 to April 30, 2020 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Covid-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant woman suffering from a confirmed or suspected COVID-19 infection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Adult woman (≥18 years old)&#xD;
&#xD;
          -  Pregnant woman&#xD;
&#xD;
          -  Suffering from a confirmed or suspected COVID-19 infection&#xD;
&#xD;
          -  Patient who has been medically treated at Strasbourg University Hospitals as well as&#xD;
             for his newborn baby, between 03/01/2020 and April 30, 2020&#xD;
&#xD;
          -  Woman having given, after information, her agreement for the reuse of her data for the&#xD;
             purposes of this research&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patient who expressed her opposition to participating in the study&#xD;
&#xD;
          -  Patient under guardianship or under guardianship&#xD;
&#xD;
          -  Patient under legal protection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Philippe DERUELLE, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe DERUELLE, MD, PhD</last_name>
    <phone>33 3 88 12 84 55</phone>
    <email>philippe.deruelle@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe DERUELLE, MD, PhD</last_name>
      <phone>33 3 88 12 84 55</phone>
      <email>philippe.deruelle@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <phone>33 3 88 11 66 90</phone>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Philippe DERUELLE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fanny DE MARCILLAC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Kuhn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlotte Jouffrieau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samira Fafi-Kremer, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 7, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>COVID-19 Pandemic</keyword>
  <keyword>Sars-cov-2</keyword>
  <keyword>Pregnant women</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

